Key result
Heart failure hospitalizations reveal significant treatment gaps, including only 6% ARNI use among eligible patients.
Why the study?
The 2020 American College of Cardiology/AHA performance measures for heart failure provided a new set of quality-of-care tools, prompting an evaluation of their achievement within the Veterans Affairs hospital system.
Observational (n=289,810)
Yes
Significant treatment gaps and site-level variations exist in the implementation of guideline-directed medical therapies for heart failure within the Veterans Affairs system, highlighting opportunities for quality improvement.
No takes yet. Share an insight, caveat, or question.
GDMT gaps in VA HF care warrant targeted QI; leaves open whether interventions improve uptake in large integrated systems.
Warner et al. (2022) conducted an observational in Heart failure (n=289,810). Evaluation of 289,810 heart failure hospitalizations revealed significant treatment gaps, including low ARNI use (6.0% of eligible patients) and low target dose achievement for beta blockers (45.9%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: